Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › Sequencing › BGI, Australian Firm Sign MOU to Develop Dx Technology

BGI, Australian Firm Sign MOU to Develop Dx Technology

Aug 24, 2018
|
staff reporter

NEW YORK (GenomeWeb) – BGI said on Thursday it has signed a memorandum of understanding with Australian firm Xing Technology aimed at the translation of diagnostic technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Featured Webinar

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

What's Popular?

In Cancer

  1. Johns Hopkins-Led Team Launches Startup to Tackle Breast Cancer, Glioblastoma Applications

    Premium

  2. Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

  3. Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

  4. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  5. Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.